CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 76 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $9,000 | 0.0% | 77 | +5.5% | 0.00% | – |
Q4 2020 | $9,000 | -62.5% | 73 | -66.4% | 0.00% | – |
Q3 2020 | $24,000 | -25.0% | 217 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $32,000 | +39.1% | 217 | 0.0% | 0.00% | – |
Q1 2020 | $23,000 | -8.0% | 217 | 0.0% | 0.00% | – |
Q4 2019 | $25,000 | -10.7% | 217 | -11.1% | 0.00% | – |
Q3 2019 | $28,000 | +16.7% | 244 | -2.4% | 0.00% | – |
Q2 2019 | $24,000 | +4.3% | 250 | 0.0% | 0.00% | – |
Q1 2019 | $23,000 | +9.5% | 250 | -8.4% | 0.00% | – |
Q4 2018 | $21,000 | +75.0% | 273 | +78.4% | 0.00% | – |
Q3 2018 | $12,000 | -20.0% | 153 | 0.0% | 0.00% | – |
Q2 2018 | $15,000 | +25.0% | 153 | 0.0% | 0.00% | – |
Q1 2018 | $12,000 | – | 153 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Maso Capital Partners Ltd | 627,111 | $74,068,000 | 20.20% |
Athos Capital Ltd | 362,909 | $42,863,000 | 11.81% |
PSquared Asset Management AG | 205,000 | $24,213,000 | 3.85% |
York Capital Management Global Advisors, LLC | 302,675 | $35,749,000 | 3.52% |
HHLR ADVISORS, LTD. | 2,962,076 | $349,851,000 | 2.78% |
ALPINE ASSOCIATES MANAGEMENT INC. | 534,180 | $63,092,000 | 2.58% |
Pentwater Capital Management LP | 1,178,000 | $139,134,000 | 1.68% |
Temasek Holdings (Private) Ltd | 1,240,000 | $146,456,000 | 0.63% |
AQR Arbitrage LLC | 142,733 | $16,858,000 | 0.59% |
FORT, L.P. | 9,761 | $1,153,000 | 0.34% |